PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts

Blood

Volumn 120, Issue 15, 2012, Pages 3126-3135

  Chitu, Violeta ^a   Nacu, Viorel ^a   Charles, Julia F ^b,c   Henne, William M ^d   McMahon, Harvey T ^e   Nandi, Sayan ^a   Ketchum, Halley ^a   Harris, Renee ^a   Nakamura, Mary C ^b,c   Stanley, E Richard ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d School of Integrative Plant Sciences   (United States)

^e MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROLINE RICH PROTEIN; PROLINE SERINE THREONINE PHOSPHATASE INTERACTING PROTEIN 2; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE LESION; CELL ACTIVATION; CELL DIFFERENTIATION; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; GENE MUTATION; MACROPHAGE; MALE; MOUSE; MULTIPOTENT STEM CELL; MYELOID PROGENITOR CELL; MYELOPOIESIS; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOPENIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

EID: 84867803403     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-425595     Document Type: Article

References (56)

1. Schett G. Osteoimmunology in rheumatic diseases. Arthritis Res Ther. 2009;11(1):210.
2. El-Shanti H, Ferguson PJ. Chronic recurrent multifocal osteomyelitis: a concise review and genetic update. Clin Orthop Relat Res. 2007;462:11-19. (Pubitemid 47367837)
3. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 1998;95(7):3597-3602.
4. Chitu V, Stanley ER. Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol. 2006;18(1):39-48. (Pubitemid 43049646)
5. Boyle JW, Simone WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337-342. (Pubitemid 40852708)
6. Hodge JM, Kirkland MA, Nicholson GC. Multiple roles of M-CSF in human osteoclastogenesis. J Cell Biochem. 2007;102(3):759-768. (Pubitemid 47557428)
7. Perkins SE, Kling SJ. Local concentrations of macrophage-stimulating factor mediate osteoclastic differentation. Am J Physiol. 1995;296(6 Pt 1):E1024-E1030.
8. Arai F, Miyamoto T, Ohneda O, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med. 1999;190(12):1741-1754. (Pubitemid 30013841)
9. Tanaka S, Takahashi N, Udagawa N, et al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest. 1993;91(1):257-263. (Pubitemid 23037280)
10. Chitu V, Stanley ER. PCH proteins, coordinators of membrane-cytoskeletal interactions. Trends in Cell Biology. 2007;17(3):145-156. (Pubitemid 46341827)
11. Grosse J, Chitu V, Marquardt A, et al. Mutation of mouse MAYP/PSTPIP2 causes a macrophage autoinflammatory disease. Blood. 2006;107(8):3350-3358.
12. Petti F, Thelemann A, Kahler J, et al. Temporal quantitation of mutant Kit tyrosine kinase signaling attenuated by a novel thiophene kinase inhibitor OSI-930. Mol Cancer Ther. 2005;4(8):1186-1197. (Pubitemid 41149566)
13. Yeung YG, Soldera S, Stanley ER. A novel macrophage actin-associated protein (MAYP) is tyrosine-phosphorylated following colony stimulating factor-1 stimulation. J Biol Chem. 1998;273(46):30638-30642. (Pubitemid 28545543)
14. Chitu V, Ferguson P, de Bruijn R, et al. Primed innate immunity leads to autoinflammatory disease in PSTPIP2-defcient cmo mice. Blood. 2009;114(12):2497-24505.
15. Ferguson PJ, Bing X, Vasef MA, et al. A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone. 2006;38(1):41-47. (Pubitemid 43006073)
16. Ferguson PJ, El-Shanti H. Autoinflammatory bone disorders. Curr Opin Rheumatol. 2007;19(5):492-498. (Pubitemid 47344244)
17. Hentunen T, Choi S, Boyce B, et al. A murine model of inflammatory bone disease. Bone. 2000;26(2):183-188. (Pubitemid 30029212)
18. Nandi S, Akhter MP, Seifert MF, Dai XM, Stanley ER. Developmental and functional significance of the CSF-1 proteoglycan chondroitin sulfate chain. Blood. 2005;107(2):786-795. (Pubitemid 43076407)
19. Dai XM, Zong XH, Akhter MP, Stanley ER. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone. J Bone Miner Res. 2004;19(9):1441-1451. (Pubitemid 41094345)
20. Chitu V, Yeung YG, Yu W, Stanley ER. Measurement of macrophage growth and differentiation. In Coligan JE, Bierer BE, Marguiles DH, Strober W, eds. Current Protocols in Immunology. John Wiley and Sons. Somerset, NJ. 2011;92:14.20.11-14.20.26.
21. Faccio R, Zou W, Colaianni G, Teitelbaum SL, Ross FP. High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype. J Cell Biochem. 2003;90(5):871-883. (Pubitemid 37467103)
22. Kara FM, Chitu V, Sloan J, et al. Adenosine A1R play a critical role in osteoclast formation and function. FASEB J. 2010;24(7):2325-2333.
23. Tintut Y, Parhami F, Tsingotjidou A, Tetradis S, Territo M, Demer LL. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem. 2002;277(16):14221-14226. (Pubitemid 34968036)
24. Chitu V, Pixley FJ, Macaluso F, et al. The PCH family member MAYP/PSTPIP2 directly regulates F-actin bundling and enhances filopodia formation and motility in macrophages. Mol Biol Cell. 2005;16(6):2947-2959. (Pubitemid 40741238)
25. Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest. 1992;90(4):1622-1627.
26. Zsebo KM, Wypych J, McNiece IK, et al. Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell. 1990;63(1):195-201.
27. DeNardo DG, Brennan DJ, Rexhepaj E, et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 2011;1(1):54-67.
28. Tsujita K, Suetsugu S, Sasaki N, Furutani M, Oikawa T, Takenawa T. Coordination between the actin cytoskeleton and membrane deformation by a novel membrane tubulation domain of PCH proteins is involved in endocytosis. J Cell Biol. 2006;172(2):269-279. (Pubitemid 43112973)
29. Henne WM, Boucrot E, Meinecke M, et al. FCHo proteins are nucleators of clathrin-mediated endocytosis. Science. 2010;328(5983):1281-1284.
30. Shimada A, Niwa H, Tsujita K, et al. Curved EFC/F-BAR-domain dimers are joined end to end into a filament for membrane invagination in endocytosis. Cell. 2007;129(4):761-772. (Pubitemid 46813111)
31. Peter B, Kent H, Mills I, et al. BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. Science. 2004;303(5657):495-499. (Pubitemid 38120842)
32. Arron JR, Choi Y. Bone versus immune system. Nature. 2000;408(6812):535- 536.
33. Walsh MC, Kim N, Kadono Y, et al. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol. 2006;24:33-63.
34. Wei S, Lightwood D, Ladyman H, et al. Modulation of CSF-1-regulated post-natal development with anti-CSF-1 antibody. Immnobiology. 2005;210(2-4):109-119. (Pubitemid 41025151)
35. Clarke B. Normal Bone Anatomy and Physiology. Clin J Am Soc Nephrol. 2008;3(Suppl 3):S131-S139.
36. Yu X, Huang Y, Collin-Osdoby P, Osdoby P. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res. 2004;19(12):2065-2077. (Pubitemid 41103422)
37. Oba Y, Lee JW, Ehrlich LA, et al. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. Exp Hematol. 2005;33(3):272-278. (Pubitemid 40261308)
38. Broxmeyer HE, Cooper S, Hangoc G, Gao JL, Murphy PM. Dominant myelopoietic effector functions mediated by chemokine receptor CCR1. J Exp Med. 1999;189(12):1987-1992. (Pubitemid 29295898)
39. Vallet S, Raje N, Ishitsuka K, et al. MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts. Blood. 2007;110(10):3744-3752. (Pubitemid 350159645)
40. Ivanova N, Dimos J, Schaniel C, Hackney J, Moore K, Lemischka I. A stem cell molecular signature. Science. 2002;298(5593):601-604.
41. Yu W, Chen J, Xiong Y, Pixley FJ, Yeung YG, Stanley ER. Macrophage proliferation is regulated through CSF-1 receptor tyrosines 544, 559, and 807. J Biol Chem. 2012;287(17):13694-13704.
42. Takeshita S, Faccio R, Chappel J, et al. c-Fms tyrosine 559 is a major mediator of M-CSF-induced proliferation of primary macrophages. J Biol Chem. 2007;282(26):18980-18990. (Pubitemid 47100186)
43. Wipff J, Adamsbaum C, Kahan A, Job-Deslandre C. Chronic recurrent multifocal osteomyelitis. Joint Bone Spine. 2011;78(6):555-560.
44. Guleria I, Pollard JW. The trophoblast is a component of the innate immune system during pregnancy. Nat Med. 2000;6(5):589-593. (Pubitemid 30305912)
45. Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000;289(5484):1504-1508.
46. Brown A, Wilkinson C, Waterman S, et al. Genetic regulators of myelopoiesis and leukemic signaling identified by gene profiling and linear modeling. J Leukoc Biol. 2006;80(2):430-447.
47. Mensah KA, Ritchlin CT, Schwarz EM. RANKL induces heterogeneous DC-STAMPlo and DC-STAMPhi osteoclast precursors of which the DC-STAMPlo precursors are the master fusogens. J Cell Physiol. 2010;223(1):76-83.
48. Vignery A. Macrophage fusion: the making of osteoclasts and giant cells. J Exp Med. 2005;202(3):337-340. (Pubitemid 41126949)
49. Richard JP, Leikina E, Langen R, et al. Intracellular curvature-generating proteins in cell-to-cell fusion. Biochem J. 2011;440(2):185-193.
50. Wu Y, Dowbenko D, Lasky LA. PSTPIP 2, a second tyrosine phosphorylated, cytoskeletal-associated protein that binds a PEST-type protein-tyrosine phosphatase. J Biol Chem. 1998;273(46):30487-30496. (Pubitemid 28545524)
51. Merriman T, Cordell H, Eaves I, et al. Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases. Diabetes. 2001;50(1):184-194. (Pubitemid 32047998)
52. Pickard B, Malloy P, Clark L, et al. Candidate psychiatric illness genes identified in pacients with pericentric inversions of chromosome 18. Psychiatric Genetics. 2005;15:37-44. (Pubitemid 40411569)
53. Golla A, Jansson A, Ramser J, et al. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet. 2002;10(3):217-221. (Pubitemid 34449721)
54. Jansson A, Renner E, Ramser J, et al. Classification of non-bacterial oteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology. 2007;46(1):154-160. (Pubitemid 44932805)
55. Hurtado-Nedelec M, Chollet-Martin S, Chapeton D, Hugot JP, Hayem G, Gérard B. Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2 genes. J Rheumatol. 2010;37(2):401-409.
56. Descamps FJ, Van den Steen PE, Nelissen I, Van Damme J, Opdenakker G. Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes. Adv Exp Med Biol. 2003;535:69-77.